LWA
BIIB icon

Lebenthal Wealth Advisors’s Biogen BIIB Stock Holding History

Lebenthal Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$347K Buy
+1,433
New +$378K 1.02% 43

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lebenthal Wealth Advisors's BIIB Position: Q2 2016 in Review

Lebenthal Wealth Advisors opened a new position in Biogen (BIIB) in Q2 2016: 1,433 shares worth $347K. The stake represents 1.02% of the portfolio and ranks #43 among its holdings.

965 funds tracked by Wall St. Rank hold BIIB as of Q2 2016.

  • Lebenthal Wealth Advisors held 1,433 shares of Biogen worth $347K as of Q2 2016.
  • Biogen was a new Lebenthal Wealth Advisors position in Q2 2016.
  • Biogen made up 1.02% of Lebenthal Wealth Advisors's portfolio in Q2 2016, its #43 holding.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q2 2016.

Based on Lebenthal Wealth Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.